Bilateral comparison of two botulinum toxin type A solutions for latero-orbital facial lines: Double blind study of Botox® versus Xeomin®;Seitenvergleich zweier Botulinumtoxin-A-Präparate bei lateroorbitalen Mimikfalten: Doppelblindstudie Botox® versus Xeomin®

Journal fur Asthetische Chirurgie

Volumn 2, Issue 4, 2009, Pages 199-202

  Quarta, M ^a  

^a Ambulantes OP Zentrum Herborn   (Germany)

Author keywords

Botox ; Botulinum toxin type A; Double blind study; Latero orbital lines; Wrinkle injection; Xeomin

Indexed keywords

EID: 84873977450     PISSN: 18674305     EISSN: 18674313     Source Type: Journal    
DOI: 10.1007/s12631-009-0053-8     Document Type: Article

References (16)

1. Carruthers JDA, Glogau RG, Blitzer A (2008) Advances in facial rejuvenation: Botulinum toxin type a, hyaluronic acid dermal fillers and combination therapies-consensus recommendations. Plast Reconstr Surg 121(suppl):5-30
2. Fritsch C (2006) Wirksamkeit des neuen, komplexprotein-freien Botulinumtoxins (Xeomin) in der Therapie mimischer Lachfalten. Kosmet Med 27:124-129
3. Jost WH, Blümel J, Grafe S (2007) Botulinum toxin type A free of complexing-proteins (Xeomin) in focal dystonia. Drugs 67:669-683
4. Karsai S, Adrian R, Hammes S et al (2007) A randomized double-blind study of the effect of botox and dysport/reloxin on forehead wrinkles and electromyographic activity. Arch Dermatol 143:1447-1448
5. Khorram R (2006) Faltentherapie mit einem neuen deproteinisierten Botulinumtoxin A (Xeomin) bei 40 Patienten. Plast Chir 6(Suppl.1):55
6. Kranz G, Haubenberger D, Voller B et al (2009) Respective potencies of botox and dysport in a human skin model: a randomized, double-blind study. Mov Disord 24:231-236
7. Lowe NJ (2007) Overview of botulinum neurotoxins. J Cosmet Laser Ther 9(suppl 1):11-16
8. Lowe NJ, Ascher B, Heckmann M et al (2005) Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type a in subjects with crow's feet. Dermatol Surg 31:257-262
9. Lowe P, Patnaik R, Lowe NJ (2006) Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: A double-blind, randomized study. J Am Acad Dermatol 55:975-980
10. Prager W, Zschocke I, Turnbull K, Steinkraus V (2007) Wirksamkeit und Verträglichkeit des neuen, komplexproteinfreien Botulinumtoxins (Xeomin) bei der Behandlung von mimischen Falten-Untersuchungsergebnisse. Kosm Med 28:81-84
11. Quarta M (2008) Integration ästhetischer Eingriffe in die ambulante MKG-Praxis. MKG-Chirurg 1:207-213
12. Quarta M (2009) Paralysierende Gesichtsfalten-behandlung mit Botulinumtoxin. MKG-Chirurg 2(3): 169-174
13. Ranoux D, Gury C, Fondarai J et al (2002) Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72:459-462
14. Roggenkämper P, Jost WH, Bihari K et al (2006) Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 113:303-312
15. Sampaio C, Costa J, Ferreira JJ (2004) Clinical comparability of marketed formulations of botulinum toxin. Mov Disord 19(suppl 8):129-136
16. Talarico-Filho S, Mendonca do Nascimento M, Sperandeo de Macedo F, De Sanctis Pecora C (2007) A double-blind, randomized, comparative study of two type a botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg 33:44-50